Meridian Bioscience Inc
NASDAQ:VIVO
Intrinsic Value
Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. [ Read More ]
The intrinsic value of one VIVO stock under the Base Case scenario is 12.31 USD. Compared to the current market price of 33.97 USD, Meridian Bioscience Inc is Overvalued by 64%.
Valuation Backtest
Meridian Bioscience Inc
Run backtest to discover the historical profit from buying and selling VIVO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Meridian Bioscience Inc
Current Assets | 210.6m |
Cash & Short-Term Investments | 81.5m |
Receivables | 47.2m |
Other Current Assets | 81.9m |
Non-Current Assets | 252.5m |
PP&E | 50.7m |
Intangibles | 190.4m |
Other Non-Current Assets | 11.4m |
Current Liabilities | 58m |
Accounts Payable | 17.8m |
Accrued Liabilities | 25.7m |
Other Current Liabilities | 14.5m |
Non-Current Liabilities | 37.1m |
Long-Term Debt | 25m |
Other Non-Current Liabilities | 12.1m |
Earnings Waterfall
Meridian Bioscience Inc
Revenue
|
333m
USD
|
Cost of Revenue
|
-144.7m
USD
|
Gross Profit
|
188.4m
USD
|
Operating Expenses
|
-112.8m
USD
|
Operating Income
|
75.6m
USD
|
Other Expenses
|
-33.1m
USD
|
Net Income
|
42.5m
USD
|
Free Cash Flow Analysis
Meridian Bioscience Inc
VIVO Profitability Score
Profitability Due Diligence
Meridian Bioscience Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Meridian Bioscience Inc's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
VIVO Solvency Score
Solvency Due Diligence
Meridian Bioscience Inc's solvency score is 97/100. The higher the solvency score, the more solvent the company is.
Score
Meridian Bioscience Inc's solvency score is 97/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VIVO Price Targets Summary
Meridian Bioscience Inc
Ownership
VIVO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
VIVO Price
Meridian Bioscience Inc
Average Annual Return | 27.26% |
Standard Deviation of Annual Returns | 69.87% |
Max Drawdown | -59% |
Market Capitalization | 1.5B USD |
Shares Outstanding | 43 827 800 |
Percentage of Shares Shorted | 13.51% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. The company is headquartered in Cincinnati, Ohio and currently employs 765 full-time employees. The firm is engaged in the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain gastrointestinal and respiratory infectious diseases and elevated blood lead levels. The firm's segments include Diagnostics and Life Science. The Diagnostics segment consists of manufacturing operations for infectious disease products in Cincinnati, Ohio; Quebec City, Canada; and Modi' in, Israel. The segment also includes blood chemistry products in Billerica, Massachusetts and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment consists of manufacturing operations in Memphis, Tennessee; Boca Raton, Florida; London, England; and Luckenwalde, Germany; and the sale and distribution of bulk antigens, antibodies, polymerase chain reaction (PCR)/quantitative PCR (qPCR) reagents, nucleotides, and bioresearch reagents domestically and abroad.
Contact
IPO
Employees
Officers
The intrinsic value of one VIVO stock under the Base Case scenario is 12.31 USD.
Compared to the current market price of 33.97 USD, Meridian Bioscience Inc is Overvalued by 64%.